{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:52:26Z","timestamp":1779205946330,"version":"3.51.4"},"reference-count":47,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"8","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Precis Oncol"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n            <jats:title>PURPOSE<\/jats:title>\n            <jats:p>Individuals with Lynch syndrome (LS) are at a high lifetime risk of colorectal cancer (CRC) and other cancers. Aspirin (ASA), a nonsteroidal anti-inflammatory drug (NSAID), has proven chemopreventive benefits in LS, with the CAPP2 randomized double-blind placebo-controlled trial demonstrating a 60% relative risk reduction for CRC among participants who adhered to ASA for 2 years or more. This study sought to characterize uptake of ASA\/NSAIDs among individuals with LS and to understand factors associated with use.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>Individuals with LS were invited (June 2020-August 2022) to complete a one-time electronic survey about LS screening behaviors, uptake of ASA\/NSAIDs, and current\/emerging cancer prevention options. Participants were recruited from the Fox Chase Cancer Center (FCCC) Risk Assessment Program Registry and through a research invitation posted to two patient-facing LS advocacy websites.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>\n              Two hundred and ninety-six participants completed the survey including 116 (39.2%) from FCCC and 180 (60.8%) recruited via the Internet, including 14.9% non-US based individuals. Uptake of regular ASA or NSAIDs was modest at 34.8% and was even lower (25.7%) when focusing on individuals taking ASA or NSAIDs solely for chemoprevention of LS. More than half (55%) were taking &lt;100 mg ASA daily. In multivariable modeling, lower perceived threat of LS (odds ratio [OR], 0.84 [95% CI, 0.72 to 0.98]), lower\n              <jats:italic>concern for side effects<\/jats:italic>\n              (OR, 0.86 [95% CI, 0.76 to 0.99]), and higher\n              <jats:italic>likelihood of recommending ASA\/NSAIDs to family or a friend<\/jats:italic>\n              were all associated with ASA\/NSAIDs use (OR, 1.70 [95% CI, 1.37 to 2.10]).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Uptake of ASA\/NSAIDs chemoprevention is modest among individuals with LS. Patient perceptions of the pros and cons of ASA, more so than demographic and disease-related factors, were associated with chemoprevention uptake.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1200\/po-24-00562","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T18:29:15Z","timestamp":1731695355000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":6,"title":["Uptake of Aspirin Chemoprevention in Patients With Lynch Syndrome"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0114-8130","authenticated-orcid":true,"given":"Sachi","family":"Singhal","sequence":"first","affiliation":[{"name":"Department of Clinical Genetics, Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma D.","family":"Riggs","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen J.","family":"Ruth","sequence":"additional","affiliation":[{"name":"Bioinformatics and Biostatistics, Fox Chase Cancer Center, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3380-0858","authenticated-orcid":true,"given":"Juan Pablo","family":"Chavez-Salas","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yana","family":"Chertock","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary B.","family":"Daly","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4515-3409","authenticated-orcid":false,"given":"Michael J.","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0693"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-018-00117-1"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.5194"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.0012"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21448"},{"key":"e_1_3_7_7_2","first-page":"89","article-title":"Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors","volume":"14","author":"Rawla P","year":"2019","unstructured":"Rawla P, Sunkara T, Barsouk A: Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors. Prz Gastroenterol 14:89-103, 2019","journal-title":"Prz Gastroenterol"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00228-5"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70168-5"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-013-1745-2"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.12.032"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33224"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-021-01472-8"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.06.047"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(89)90442-X"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90519-Q"},{"key":"e_1_3_7_17_2","first-page":"4399","article-title":"Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne Colorectal Cancer Study","volume":"48","author":"Kune GA","year":"1988","unstructured":"Kune GA, Kune S, Watson LF: Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne Colorectal Cancer Study. Cancer Res 48:4399-4404, 1988","journal-title":"Cancer Res"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.097"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006293422603"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-020-00189-y"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61049-0"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30366-4"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320946"},{"key":"e_1_3_7_24_2","first-page":"973","article-title":"Relationships among breast cancer perceived absolute risk, comparative risk, and worries","volume":"9","author":"Lipkus IM","year":"2000","unstructured":"Lipkus IM, Kuchibhatla M, McBride CM, et al: Relationships among breast cancer perceived absolute risk, comparative risk, and worries. Cancer Epidemiol Biomarkers Prev 9:973-975, 2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.14.3.232"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-014-9724-5"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1159\/000517486"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12184-y"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.07.030"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13053-019-0127-3"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv170"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz233"},{"key":"e_1_3_7_33_2","unstructured":"National Comprehensive Cancer Network: Genetic\/familial high-risk assessment colorectal v1.2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_ceg.pdf"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30973-9"},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-017-9986-9"},{"key":"e_1_3_7_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-016-9933-1"},{"key":"e_1_3_7_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199112053252301"},{"key":"e_1_3_7_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djk132"},{"key":"e_1_3_7_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.8.914"},{"key":"e_1_3_7_40_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.09.035"},{"key":"e_1_3_7_41_2","doi-asserted-by":"crossref","unstructured":"Bibbins-Domingo K; US Preventive Services Task Force: Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 164:836-845 2016","DOI":"10.7326\/M16-0577"},{"key":"e_1_3_7_42_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1141810"},{"key":"e_1_3_7_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.11.027"},{"key":"e_1_3_7_44_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.8077"},{"key":"e_1_3_7_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70389-8"},{"key":"e_1_3_7_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2012.60"},{"key":"e_1_3_7_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv590"},{"key":"e_1_3_7_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.109"}],"container-title":["JCO Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/PO-24-00562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T18:29:17Z","timestamp":1731695357000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/PO-24-00562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1200\/PO-24-00562"],"URL":"https:\/\/doi.org\/10.1200\/po-24-00562","relation":{},"ISSN":["2473-4284"],"issn-type":[{"value":"2473-4284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"2024-08-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2400562"}}